Premium Information is available for this item - Upgrade for $1 a day
6505-01-169-5319
Usp Sodium Lactate Injection
6505011695319 011695319 NDC00074-6664-02
May 2023
5
Marketplace 6505-01-169-5319
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-169-5319 5+ Documents (More...)
/fsg-65/fsc-6505/dk
6505-00-116-1134 6505-00-116-1158 6505-22-116-5883 Lactate Injection 6505001161158 116-1158 6505-01-169-5319
6505-00-116-1134 6505-00-116-1158 6505-22-116-5883 Lactate Injection 6505001161134 116-1134 6505-01-169-5319
Injection 6505006197719 us 6505-00-045-8396 Usp Sodium Lactate Injection 6505000458396 045-8396 6505-01-169-5319
6505-00-116-1134 us 6505-00-116-1158 Usp Sodium Lactate Injection 6505001161158 116-1158 6505-01-169-5319
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-116-1158 Usp Sodium Lactate Injection 6505001161158 116-1158 6505-01-169-5319
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-116-1134 Usp Sodium Lactate Injection 6505001161134 116-1134 6505-01-169-5319
Usp Sodium Lactate Injection 6505011695319 available for this item - Upgrade for $1 a day Upgrade
) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-619-7719 Usp Sodium Lactate 116-1134 6505-01-169-5319
/fsg-65/fsc-6505/uk
Usp Sodium Lactate Injection 6505011695319 Documents ( More... ) https//www.nsnlookup.com /fsg-
6505006197719 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-045-8396 Usp Sodium Lactate Injection -1134 6505-01-169-5319
Restrictions 6505-01-169-5319
6505-01-169-5319 is a Usp Sodium Lactate Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-169-5319
- NASA (G652)
- Effective Date:
- 1 Apr 1991
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-169-5319
- Part Number
- Manufacturer
- Status
- NDC00074-6664-02
- Manufacturer
- 60060 - Abbott Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
Datasheet 6505-01-169-5319
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 5.000 Milliequivalents Sodium Lactate Per Milliliter
- Administration [CSGS]
- Intravenous
- Primary Container Type [CQCT]
- Vial
- Primary Container Content Quantity [CRLK]
- 10.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 50
- Special Features [FEAT]
- 20 Ml. Fliptop Vial
- Therapeutic Equivalent [THPE]
- Not Rated
Management Data 6505-01-169-5319
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- May 1986
- Veterans Administration (VA)
- PG
- Subscribe
- PG
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 50 Ea
- 00000000050EA
- K
NATO Stock Numbers Related to 6505-01-169-5319
Freight Information 6505-01-169-5319
6505-01-169-5319 has freight characteristics.. 6505-01-169-5319 has a variance between NMFC and UFC when transported by rail and the description should be consulted.